article thumbnail

New FDA guidance on addressing misinformation under White House review

Agency IQ

BY LAURA DIANGELO, MPH A new question-and-answer draft guidance document focused on “addressing misinformation” about regulated life sciences products is currently under administrative review at the White House’s Office of Information and Regulatory Affairs (OIRA). Fill out the form to read the full article.

FDA 59
article thumbnail

Bogus ‘Cure’ Claims Have U.S. Consumers Snapping Up CBD Products

The Pharma Data

A random sample of 376 posts labeled testimonials found that 90% cited using CBD to treat diagnosable medical conditions. Nearly two-thirds of the testimonials discussed its use for treating mental or emotional problems. Nearly two-thirds of the testimonials discussed its use for treating mental or emotional problems.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Bayer announces filing of petition to U.S. Supreme Court for review of Hardeman decision

The Pharma Data

Second, the admission of expert testimony departed from federal standards, enabling plaintiff’s causation witnesses to provide unsupported testimony on the principal issue in the case, Roundup ’s safety profile. First, the state-law failure-to-warn claims at the center of the case are preempted by federal law, as the U.S.

article thumbnail

Digital Product Catalog: The Medical Device Marketer’s Guide

Perficient: Drug Development

Benefits, product information, specifications, ordering information and costs are the tables takes — no product page is complete without those. Perhaps there is a text-based testimonial by a loyal user or a video giving a glimpse of the manufacturing and QA process. Contact us today for more information.

article thumbnail

Reverse Diabetes

The Pharma Data

The Testimonials below are unedited, and have been submitted from real people just like you. None of these people were compensated for their testimonial. I showed her some of your information and the sample diet. The information contained on this website is. provided for general informational purposes only.

article thumbnail

Analysis Chemical Thank You Senate hearing on hazardous substance listing for PFAS finds common ground, but disagreements on implementation tactics

Agency IQ

The testimony of witnesses and the Senators themselves largely agreed on the designation, but diverged on questions of liability exemptions. In addition, the EPA also requested information on designating the precursors to PFOA, PFOS, and the seven PFAS included in ANPRM, as well as “categories of PFAS.” DEBBIE STABENOW (D-Mich.),

article thumbnail

Free High Blood Pressure Presentation

The Pharma Data

The information contained on this website is. provided for general informational purposes only. Testimonials are from real persons who are. The information contained on this website is. provided for general informational purposes only. Testimonials are from real persons who are. If you are. Results may vary.